Vitaz
Sint-Niklaas, Belgium
10 recruiting
Showing 1–13 of 13 trials
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Hoffmann-La Roche600 enrolled362 locationsNCT06819878
Recruiting
Phase 3
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Gilead Sciences695 enrolled205 locationsNCT06801834
Recruiting
Phase 3
FOLICOLOR TRIAL: Following Therapy Response Through Liquid Biopsy in Metatstatic Colorectal Cancer Patients
Advanced Colorectal Cancer
University Hospital, Antwerp150 enrolled9 locationsNCT07558083
Recruiting
Phase 3
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Non-Muscle Invasive Bladder Neoplasms
Janssen Research & Development, LLC641 enrolled193 locationsNCT06319820
Recruiting
A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma
Relapsed/Refractory Multiple Myeloma
Janssen Pharmaceutica N.V., Belgium300 enrolled87 locationsNCT05160584
Recruiting
Phase 3
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Squamous Cell Carcinoma of Head and Neck
Janssen Research & Development, LLC500 enrolled160 locationsNCT07276399
Recruiting
Phase 3
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
Crohn's Disease
Janssen-Cilag Ltd.112 enrolled84 locationsNCT06408935
Recruiting
Phase 2Phase 3
INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC
Head and Neck Squamous Cell Carcinoma (HNSCC)
Inhibrx Biosciences, Inc410 enrolled88 locationsNCT06295731
Recruiting
Study on the Clinical Efficacy of Teclistamab
Multiple MyelomaHematologic Diseases
Universitaire Ziekenhuizen KU Leuven100 enrolled17 locationsNCT06477783
Recruiting
Not Applicable
Continuous Glucose Monitoring for Women with Gestational Diabetes
Gestational Diabetes
Universitaire Ziekenhuizen KU Leuven386 enrolled14 locationsNCT06310356
Recruiting
Phase 3
Semaglutide for the Treatment of Glucose Intolerance in Women with Prior Gestational Diabetes
Glucose Intolerance After a Recent History of Gestational Diabetes
Universitaire Ziekenhuizen KU Leuven252 enrolled13 locationsNCT05569772
Recruiting
Phase 4
Prevention of Postoperative Endoscopic Recurrence with Endoscopy-driven Versus Systematic Biological Therapy
Crohn Disease
Universitaire Ziekenhuizen KU Leuven292 enrolled28 locationsNCT05169593
Recruiting
Differential Target Multiplexed Spinal Cord Stimulation
Failed Back Surgery SyndromePersistent Spinal Pain Syndrome Type 2
Moens Maarten250 enrolled14 locationsNCT05068011